This week · live digest
Updated ·
Macro regime · as of 2026-06-14
VIX
elevated
Breadth · % above 200d
broad
SPX vs 200d EMA
above trend
Conviction moves · last 7 days
No conviction tier changed in the last seven days. Moves appear here the moment the model re-rates a name.
New & refreshed · last 7 days
AA
freshAlcoa Corporation
Aluminum-deficit MATURING→rolling over: -7.9% distribution off highs, no fresh upgrade 15d, Hormuz de-escalation = binary-in-reverse at beta ~2. WATCH for a higher-low base; late-stage.
AAOI
freshApplied Optoelectronics, Inc.
Optical ACCEL but secondary to cleaner COHR; +400% YTD parabola, $600M ATM supply ceiling, ETF/MEME-saturated, ~2.2x consensus PT. Peak-sentiment chase, no catalyst ~8wks WATCH.
AAPL
freshApple Inc.
WWDC ~6/8 binary today; MATURING ai-mag7 theme, $4T mega-cap (±5-10% asymmetry) dilutes alpha on the book, edge +3.3pp fails rule 2. Consistent with prior deferrals wait for the print.
ADI
freshAnalog Devices, Inc.
Analog cyclical-trough-is-in + AI-power optionality (Empower $1.5B) narrative already fired: Q2 beat ~2026-05-20 triggered 11+ PT hikes to $440–515 by 05-26. Binary is now in the rearview and sell-side has fully caught up late validated…
AEIS
freshAdvanced Energy Industries, Inc.
Picks-and-shovels AI-datacenter power re-rating: DC Computing revenue doubled to $194.2M in Q1 (5/4) and the 6/3 ADH 800V converter launch slots AEIS into NVIDIA Rubin-era HVDC racks. Fundamentals ACCELERATING, but the tape broke down the…
AMD
freshAdvanced Micro Devices, Inc.
AI-chip ACCELERATING but (rank 34%), parabolic ATH chase, ARK persistent distribution dossier wants the ~$420 shelf retest.
AMRX
freshAmneal Pharmaceuticals, Inc.
Commodity-generics maker re-rating into specialty branded, biosimilars, and GLP-1 contract manufacturing. Q1 adj. EBITDA +19% and Specialty +23%, then June CREXONT Phase 4 data and a romidepsin FDA approval drove a +19% week to fresh…
ATEX
freshAnterix Inc.
Spectrum re-rating already paid: FCC's 2026-02-18 final rule lifting 900 MHz broadband to 10 MHz (implied $2.5–7B+ value) drove a ~3.7x run to the 52-wk high $67.19. Theme now MATURING B. Riley cut to Neutral 2026-06-04 (PT $69 ≈ spot),…
ATEYY
freshAdvantest Corporation
Record 2026-05-13 Q1 (sales +29.7%, op profit +36.5%) but FY2026 guide held FLAT, not raised a third straight time the beat-and-raise engine stalled. Shares topped ¥5,149 that day, down ~12% to ¥4,502 since. Hoka guiding HSD next quarter;…
Themes · accelerating · as of 2026-06-14
Memory trade screaming (MU/SNDK 'bulletproof', SNDK +200% 3m), TSM scarcity + price hikes, KLAC/ASML chip-equipment getting fresh billionaire bid, MRVL PT to $345, ALAB Nasdaq-100 inclusion. Core engine still accelerating; added MRVL/KLAC/ALAB/SNDK/UMC this week.
NEW low-conviction catch-all to keep these watchlist names clustered: OPEN ('real estate's Tesla moment', Eric Jackson $4→$500 thesis), LMND AI-insurtech, SNAP turnaround amid regulatory noise. Loose retail-favorite/disruption thread, not a clean cluster flagged low conf.
NEW: '7 Stocks to Buy for the World's Best Turnaround Trade' spotlights BBAR/BMA; the Argentine bank ADRs (GGAL, SUPV) are moving together on the macro-turnaround narrative. Coherent country/sector cluster.
NEW cluster crystallizing on FSD/robotaxi/L4 headlines: Rivian CEO says Tesla-FSD-like driving arrives this year + eyes-off next year, BIDU AmiGo gets Swiss L4 permit, TSLA robotaxi cadence. Carved out around the self-driving narrative.
CORT positive CATALYST trial data (Korlym -1.3% HbA1c), SEPN Raymond James Strong Buy + ENDO 2026 preclinical acceptance lead. Prior members PLSE/ZVRA/LEGN dropped out of context; backfilled with AMRX/MMED to hold the therapeutics cluster.
NEW: broad momentum sweep through beaten-up retail VSXY JPM Overweight PT $88, whale alerts across discretionary, BBY Meta Labs in-store rollout. Mixed quality (NKE downgrades, KMX Underweight) so low conf, but the basket is moving as a group.
Catalysts ahead · as of 2026-06-14
This week 32
Adaptive Biotechnologies Corporation
fda
ProFrac Holding Corp.
earnings
Baytex Energy Corp.
earnings
Canopy Growth Corporation
fda
Dave & Buster's Entertainment, Inc.
earnings
Rumble Inc.
earnings
Uniti Group Inc.
earnings
United States Oil Fund, LP
+24 more
Next week 23
Cross Country Healthcare, Inc.
earnings
Flex Ltd.
earnings
Inhibrx Biosciences, Inc.
fda
Organon & Co.
earnings
Energy Fuels Inc.
earnings
XTL Biopharmaceuticals Ltd.
fda
BlackBerry Limited
earnings
Liquidia Corporation
fda
+15 more
Later 41
QuickLogic Corporation
earnings
Sportradar Group AG
earnings
Tilray Brands, Inc.
fda
AtaiBeckley Inc.
fda
Birkenstock Holding plc
earnings
Himax Technologies, Inc.
earnings
Nike, Inc.
earnings
NovoCure Limited
fda
+33 more
Resolved · last 7 days
Thesis played out
Thesis played out
Thesis played out
Thesis played out
Thesis invalidated
Thesis played out
Thesis invalidated
Thesis invalidated
Week-ahead note
The market read flipped to RISK-ON from NEUTRAL, with the VIX still elevated at 19.44, breadth healthy at 60.6% of names above their 200-EMA, and the SPX sitting +8.5% above its own. Leadership is concentrated in tech hardware and semis, where VSH (+245.879% 3m), MRVL (+226.167%) and ALAB (+210.807%) carry the longest trends, while Consumer Cyclical's VSXY tops the composite momentum score at 75.087. The regime…